What happened
SelectQuote, Inc. (NYSE: SLQT) director Donald L. Hawks III bought 250,000 shares on Nov. 6 and Nov. 9, paying about $114,000 in total.
By OptimistFi's calculation, the purchase equals 48.7% of the direct holding Hawks had before the trade.
Hawks bought 26,598 shares on Nov. 6 at a weighted average price of $0.44, within a range of $0.40 to $0.48. On Nov. 9, Hawks bought 223,402 shares at a weighted average of $0.46, within a range of $0.45 to $0.47.
After the purchase, Hawks held 763,214 shares directly. The form also lists indirect holdings of 8,877,872 shares through BEP III LLC, 6,911,600 through BEP III Co-Invest LLC and 1,889,285 through SQ Co-investors LLC. Hawks disclaims beneficial ownership of those shares except to the extent of a pecuniary interest.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares bought | 250,000 shares | SEC Form 4 | |
| Total purchase value | about $114,000 | SEC Form 4 | |
| Weighted average price, Nov. 6 and Nov. 9 | $0.44 and $0.46 | SEC Form 4 | |
| Direct holding after the purchase | 763,214 shares | SEC Form 4 | |
| Purchase versus pre-trade direct holding | 48.7% | Calculated from SEC Form 4 |
Read more: SelectQuote (SLQT) company research
Why it matters
OptimistFi has argued that SelectQuote re-rates only if its healthcare expansion, in pharmacy and care management, diversifies revenue and improves cash generation versus the core commission business.
A director adding to a personal position is a data point on insider positioning. It says nothing about revenue mix or cash generation, the two things the case turns on.
The form was signed Nov. 10, one day after the second purchase. Both trades were priced below $1 a share, and the form reports each as a weighted average within a separate range.
Because the entity holdings sit outside the direct position, the direct stake is the cleanest measure of the personal bet.
It is also one director's trade. It does not by itself show broader insider conviction or any improvement in operating performance. OptimistFi therefore reads the purchase as mixed for the case rather than a step toward the re-rating.
Stock perps: every US stock that trades as a perpetual future, by leverage, live
What's next
SelectQuote's next quarterly report is the next test. Rising healthcare services revenue alongside stronger cash generation would give the purchase operating support, while results still carried by the core commission business would not.
More from OptimistFi
From OptimistFi Perps
- Futures calculator: liquidation price, PnL and fees by exchange
- Perp funding rates live: what longs and shorts pay on every venue
- Stock perps vs tokenized stocks: how US shares trade around the clock
- Weekend market prices: US stock indexes, gold and oil now
- Perps news: leveraged stocks, gold, FX and crypto on-chain
- Prop firms that fund crypto and stock perps traders: rules, prices and payouts
Sources
- SEC Form 4, SelectQuote, Inc. (Donald L. Hawks III) — Statement of changes in beneficial ownership covering purchases on Nov. 6 and Nov. 9, 2026, signed Nov. 10, 2026.
Explore OptimistFi research on SelectQuote, Inc.: https://optimistfi.com/stocks/SLQT
Browse SelectQuote, Inc. company coverage and explore the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
Find available research on the SelectQuote, Inc. company page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
